These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 20613519

  • 1. Current clinical use of biomarkers for epithelial ovarian cancer.
    Moore RG, Maclaughlan S.
    Curr Opin Oncol; 2010 Sep; 22(5):492-7. PubMed ID: 20613519
    [Abstract] [Full Text] [Related]

  • 2. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [Abstract] [Full Text] [Related]

  • 3. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A, Ye B.
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
    Williams TI, Toups KL, Saggese DA, Kalli KR, Cliby WA, Muddiman DC.
    J Proteome Res; 2007 Aug; 6(8):2936-62. PubMed ID: 17583933
    [Abstract] [Full Text] [Related]

  • 6. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HE4 in ovarian cancer: from discovery to clinical application.
    Montagnana M, Danese E, Giudici S, Franchi M, Guidi GC, Plebani M, Lippi G.
    Adv Clin Chem; 2011 Feb; 55():1-20. PubMed ID: 22126021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ovarian cancer screening: a look at the evidence.
    Fields MM, Chevlen E.
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
    Kolwijck E, Span PN, Thomas CM, Bulten J, Sweep FC, Massuger LF.
    Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124
    [Abstract] [Full Text] [Related]

  • 13. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A, Jurisica I, Kislinger T.
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [Abstract] [Full Text] [Related]

  • 14. Screening and detection of ovarian cancer.
    Breedlove G, Busenhart C.
    J Midwifery Womens Health; 2005 Aug; 50(1):51-4. PubMed ID: 15637515
    [Abstract] [Full Text] [Related]

  • 15. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.
    Clin Cancer Res; 2007 Mar 01; 13(5):1421-8. PubMed ID: 17332284
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Mar 01; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.